AB-Biotics SA (CATS:ABB) announced a private placement of 500,000 shares at 2.15 per share for gross proceeds of 1,075,000 with new investor on August 7, 2013. Through the transaction, the investor will acquire more than 5% stake in the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
2022 | AB-Biotics, S.A. acquired Alifarm S.A. for EUR 3.5 million. | CI |
2019 | Kaneka Europe Holding Company N.V. completed the acquisition of 18.21% stake in AB-Biotics, S.A. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 69.57M | |
-32.63% | 9.2B | |
-5.66% | 3.12B | |
+23.12% | 2.8B | |
-17.75% | 2.07B | |
-24.39% | 1.59B | |
+65.65% | 1.44B | |
+32.83% | 830M | |
-6.55% | 724M | |
-29.80% | 507M |
- Stock Market
- Equities
- ABB Stock
- News AB-Biotics, S.A.
- AB-Biotics SA announced that it expects to receive €1.08 million in funding.